Prognostic value of combined LDL-C and remnant cholesterol stratification for 24-month major adverse cardiovascular events after primary PCI in patients with STEMI
Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk, which may help identify patients with residual lipid-related risk in STEMI patients after primary PCI.
Abstract
Objective This single-center prospective observational cohort study aimed to investigate the prognostic value of combined low-density lipoprotein cholesterol (LDL-C) and remnant cholesterol (RC) stratification in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods A total of 812 STEMI patients were enrolled and stratified into four groups according to LDL-C and RC levels measured at 1-month post-PCI. The primary endpoint was 24-month major adverse cardiovascular events (MACE). Results The overall MACE rate increased stepwise across the four subgroups (P < 0.001). Multivariate Cox regression showed that elevated RC was independently associated with MACE (HR = 1.559, 95% CI: 1.018−2.386, P = 0.041), whereas isolated high LDL-C was not (HR = 1.329, 95% CI: 0.992−1.781, P = 0.057). Compared with the low LDL-C + low RC group, the high LDL-C + high RC group carried the highest MACE risk (HR = 2.535, 95% CI: 1.591–4.041, P < 0.001), followed by the low LDL-C + high RC group (HR = 1.874, 95% CI: 1.153–3.045, P = 0.011). Conclusions Combined LDL-C and RC stratification may assist risk evaluation in STEMI patients after primary PCI. Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk.
In patients with AMI despite documented prior statin exposure, the prognostic associations of residual inflammatory and Lp(a) risk appeared to differ across admission LDL-C strata, supporting the potential value of LDL-C–stratified residual risk assessment.
Dysregulated serum lipids and hyperglycemia are established risk factors for adverse outcomes in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). The Cholesterol, HDL, Glucose (CHG) index is a novel composite metric integrating glycemic and lipid profiles; however, its prognost...
Zai-Qiang Liu, Yu-Xiu Yang, Qiu-Xuan Li et al.· Scientific Reports· 0 citations
It is suggested that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population of patients with chronic coronary syndrome after percutaneous coronary intervention (PCI).
Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al.· Biomarkers in Medicine· 0 citations
Combined TG-HDL phenotyping using guideline-based cutoffs may provide a simple and clinically relevant approach to stratifying residual cardiovascular risk beyond low-density lipoprotein cholesterol lowering.
Mitsukuni Kimura, Shunsuke Katsuki, Yasuhiro Nakano et al.· Journal of atherosclerosis a...· 0 citations
In secondary prevention after PCI, AUC-derived cumulative LDL-C exposure was associated with MACCE beyond available baseline clinical characteristics and may complement snapshot LDL-C assessment.
Shigetaka Kageyama, H. Sugiyama, K. Murata et al.· Atherosclerosis· 1 citation
Achievement of LDL-C <55 mg/dL within 6 months after AMI is independently associated with a meaningful reduction in recurrent ASCVD events in real-world practice, and the temporal mismatch between early post-discharge risk and delayed lipid assessment underscores the need for proactive, multidisciplinary care models to...
Henry C. Okoroike, Wei-Li Zheng, Faisal Hasan et al.· American Journal of Cardiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.